# Prognosis and Targeted Therapy Related Molecular Screening Program for Patients of Breast Cancer in China

> **NCT03792529** · — · UNKNOWN · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 300 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** detect gene mutations of ctDNA and ctRNA

## Key facts

- **NCT ID:** NCT03792529
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-20
- **Primary completion:** 2019-06-01
- **Final completion:** 2019-06-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2019-01-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03792529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03792529, "Prognosis and Targeted Therapy Related Molecular Screening Program for Patients of Breast Cancer in China". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03792529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*